This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)
C3_BILIARY_TRACT_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
679 |
4. Check minimum number of eventsNone |
679 |
5. Include endpointsNone |
679 |
6. Filter based on genotype QC (FinnGen only) |
679 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 679 | 285 | 394 |
| Unadjusted period prevalence (%) | 0.14 | 0.10 | 0.17 |
| Median age at first event (years) | 71.06 | 70.66 | 71.35 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 394
- Matched controls
- 3939
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
298.2
247
*
A03FA01
ATC
metoclopramide; systemic, rectal
26.6
148.7
225
187
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
146.2
131
*
K83.1
ICD-10 Finland
Obstruction of bile duct
201.9
135.2
134
10
H02AB02
ATC
dexamethasone; systemic
148.9
134.5
137
14
A04AA02
ATC
granisetron; systemic, transdermal
+∞
129.5
117
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
120.1
109
*
Z51.5
ICD-10 Finland
Palliative care
61.0
118.4
137
34
UJK02
NOMESCO Finland
ERCP
62.0
115.3
133
32
JLC30
NOMESCO Finland
Pancreatoduodenectomy
697.3
110.5
104
*
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
697.3
110.5
104
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
89.0
109.4
119
19
L01BC06
ATC
capecitabine; oral
+∞
102.7
94
*
N02AA05
ATC
oxycodone; systemic
13.4
96.6
194
266
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
98.9
95.8
103
14
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
94.7
87
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
85.6
79
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
80.6
84.1
93
15
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
+∞
81.1
75
*
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
+∞
81.1
75
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
77.7
72
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
60.1
76.7
89
19
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
125.0
76.2
80
8
WX302
NOMESCO Finland
Thoracal epidural anesthesy
33.4
72.1
95
37
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
46.1
71.3
87
24
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
801.1
70.3
67
*
C24.0
ICD-10 Finland
Malignant neoplasm: Extrahepatic bile duct
+∞
69.9
65
*
JN4BD
NOMESCO Finland
Extensive body CT
17.8
68.6
112
86
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
64.3
60
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
51.8
63.8
76
18
8140/3-C24.1
ICD-O-3
Adenocarcinoma, NOS, of ampulla of Vater
+∞
58.8
55
*
C24.09
ICD-10 Finland
Biliary duct or passage NOS
+∞
56.6
53
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
304.9
53.5
53
*
C24.00
ICD-10 Finland
Hepatic duct
+∞
53.3
50
*
K83.0
ICD-10 Finland
Cholangitis
42.9
52.6
65
18
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
48.7
51.5
62
15
C24.02
ICD-10 Finland
Common bile duct
+∞
51.2
48
*
JN4CD
NOMESCO Finland
Very extensive body CT
26.0
50.6
71
33
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
36.1
49.9
64
21
8000/3-C24.9
ICD-O-3
Neoplasm, malignant of billiary tract, NOS
+∞
49.0
46
*
8160/3-C24.0
ICD-O-3
Cholangiocarcinoma of extrahepatic bile duct
+∞
49.0
46
*
A04AA01
ATC
ondansetron; systemic, rectal
23.9
43.9
63
31
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
10.1
43.0
91
114
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.1
42.2
168
502
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
42.5
42.1
52
14
JN4AD
NOMESCO Finland
Body CT examination
13.6
41.9
75
67
8140/3-C24.0
ICD-O-3
Adenocarcinoma, NOS, of extrahepatic bile duct
+∞
41.4
39
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
41.4
39
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.4
39.2
68
56
8000/3-C24.0
ICD-O-3
Neoplasm, malignant of extrahepatic bile duct
+∞
38.1
36
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
12.8
37.2
68
63
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
37.1
35
*
WZC30
NOMESCO Finland
Teaching
7.6
36.4
92
152
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.5
34.9
100
196
R50.9
ICD-10 Finland
Fever, unspecified
5.5
34.7
117
281
TPH04
NOMESCO Finland
Cathetrisation of vein
4.5
33.5
143
439
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
+∞
32.8
31
*
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
350.5
32.3
32
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
29.9
32.2
43
16
A04AA55
ATC
palonosetron, combinations; systemic
+∞
31.7
30
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.4
31.2
104
243
JAH01
NOMESCO Finland
Laparoscopy
13.4
31.0
55
47
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
+∞
30.6
29
*
B01AB10
ATC
tinzaparin; parenteral
11.5
30.4
58
58
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.3
30.1
65
82
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.3
29.6
101
241
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
+∞
29.5
28
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
28.5
27
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
28.5
27
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
301.6
28.1
28
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
155.9
28.0
29
*
B01AB05
ATC
enoxaparin; parenteral
3.6
27.6
166
665
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
27.4
26
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
11.3
26.7
51
51
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
26.3
25
*
JN3AD
NOMESCO Finland
Abdominal CT examination
6.7
25.0
67
117
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
24.2
23
*
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
24.2
23
*
8140/3-C24.9
ICD-O-3
Adenocarcinoma, NOS, of billiary tract, NOS
+∞
24.2
23
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
23.1
22
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
20.5
23.0
34
18
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
127.3
22.8
24
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
29.3
22.6
30
11
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
22.1
21
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
22.1
21
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.1
21.9
74
171
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
121.7
21.8
23
*
R4190
NOMESCO Finland
Nutritional therapy
14.5
21.4
36
27
A06AH03
ATC
naloxegol; oral
63.6
21.1
24
*
A04AD12
ATC
aprepitant; systemic
+∞
21.0
20
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
8.8
20.7
45
57
WX402
NOMESCO Finland
General anaesthesia
4.3
20.1
80
218
XX3DW
NOMESCO Finland
Time consuming IT work
6.9
19.9
51
83
L03AA02
ATC
filgrastim; parenteral
210.0
19.7
20
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
19.0
123
494
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.2
19.0
33
27
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
18.9
18
*
J01MA12
ATC
levofloxacin; systemic
3.2
18.6
115
447
WW500
NOMESCO Finland
Blood transfusion
13.3
17.9
31
25
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
38.7
17.8
22
6
D77
ICPC
Malignant digestive neopl other/NOS
+∞
16.8
16
*
A02BC02
ATC
pantoprazole; systemic
2.5
16.3
273
1860
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
166.2
15.6
16
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
15.2
84
298
JAH00
NOMESCO Finland
Laparotomy
8.8
15.1
32
39
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
+∞
14.7
14
*
116
Kela drug reimbursment
Prostate cancer
+∞
14.7
14
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
155.4
14.6
15
*
R18
ICD-10 Finland
Ascites
14.3
13.9
23
17
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.1
13.6
83
312
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
13.6
13
*
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
13.6
13
*
JDE00
NOMESCO Finland
Gastrojejunostomy
+∞
13.6
13
*
C24.01
ICD-10 Finland
Cystic duct
+∞
13.6
13
*
A06AD11
ATC
lactulose; oral
2.7
13.3
101
439
A05AA02
ATC
ursodeoxycholic acid; oral
16.1
12.7
20
13
UJK12
NOMESCO Finland
Peroral cholangioscopy
72.2
12.7
14
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
12.6
12
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
12.6
12
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.5
12.2
36
71
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
11.5
11
*
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
123.4
11.5
12
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
123.4
11.5
12
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
11.3
89
389
ZX120
NOMESCO Finland
Intravenous
3.7
11.0
49
146
WX004
NOMESCO Finland
Patient-controlled sedation
28.9
10.8
14
5
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
10.5
10
*
D76
ICPC
Malignant neoplasm pancreas
+∞
10.5
10
*
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
+∞
10.5
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
10.5
10
*
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
33.5
10.4
13
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
33.5
10.4
13
*
JKA20
NOMESCO Finland
Cholecystectomy
5.9
10.3
28
50
WX892
NOMESCO Finland
Monitored bed care
3.7
10.3
45
132
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.1
9.8
23
34
WX002
NOMESCO Finland
Sedation and analgesia
2.4
9.4
86
408
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.4
9
*
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
+∞
9.4
9
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
8.0
9.2
20
26
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
8.6
60
244
A79
ICPC
Malignancy NOS
91.9
8.4
9
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
13.1
8.4
14
11
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
8.8
8.4
17
20
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.4
8
*
JKC30
NOMESCO Finland
Partial excision of bile duct and anastomosis to jejunum
+∞
8.4
8
*
K75.0
ICD-10 Finland
Abscess of liver
+∞
8.4
8
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
8.4
8
*
R4110
NOMESCO Finland
Physiotherapy
2.1
8.3
102
552
A98
ICPC
Health maint/preventive medicine
0.5
8.2
241
2960
WF002
NOMESCO Finland
Radical radiotherapy
34.1
8.1
10
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
34.1
8.1
10
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
22.5
8.1
11
5
WX704
NOMESCO Finland
Intubation
3.7
8.0
34
98
WX725
NOMESCO Finland
Noninvasive ventilation
4.5
8.0
27
63
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.8
8.0
19
29
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
4.8
7.8
25
55
A41.9
ICD-10 Finland
Sepsis, unspecified
4.4
7.8
27
65
K85.8
ICD-10 Finland
Other acute pancreatitis
15.4
7.8
12
8
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
7.5
175
1197
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.2
7.4
27
68
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
13.7
7.4
12
9
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
7.3
7
*
Y77
ICPC
Malignant neoplasm prostate
+∞
7.3
7
*
JK3MB
NOMESCO Finland
Postoperative cholangiography
+∞
7.3
7
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
16.1
7.3
11
7
J01MA02
ATC
ciprofloxacin; systemic
1.8
7.3
163
1100
A41.8
ICD-10 Finland
Other specified sepsis
7.2
7.1
16
23
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.4
6.7
23
55
K76.9
ICD-10 Finland
Liver disease, unspecified
7.6
6.5
14
19
ZX090
NOMESCO Finland
Other technic of radiotherapy
70.9
6.4
7
*
WX882
NOMESCO Finland
High dependency care
5.7
6.4
17
31
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
11.3
6.3
11
10
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
9.5
6.3
12
13
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.1
6.3
23
59
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
+∞
6.3
6
*
C25
ICD-10 Finland
Malignant neoplasm of pancreas
+∞
6.3
6
*
8163/3-C24.1
ICD-O-3
Pancreatobiliary type carcinoma of ampulla of Vater
+∞
6.3
6
*
D13
ICPC
Jaundice
+∞
6.3
6
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
+∞
6.3
6
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
C25.7
ICD-10 Finland
Malignant neoplasm: Other parts of pancreas
+∞
6.3
6
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
6.3
6
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
6.3
6
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
6.1
165
1159
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
12.8
6.1
10
8
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
6.1
117
741
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
420
276
38.27
307.65
7.3
1.3
ug/l
35.1
3.9
1.69
393
206
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
264
99
42.99
307.65
6.7
1.7
u/ml
3109.1
82.0
0.81
249
77
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
148
16
118.00
289.64
1.5
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
264
389
10.47
185.30
5.5
1.8
g/l
0.2
0.2
4.44
252
346
(4035726)
154
139
14.04
151.74
1.6
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
263
504
7.89
143.38
9.1
2.2
umol/l
49.5
8.2
12.10
245
441
(40768441) Liver Pathology biopsy report
80
23
39.29
128.72
1.4
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
128
122
12.70
120.84
1.7
1.3
ug/g
126.2
306.1
12.61
81
72
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
420
1557
5.45
105.35
9.1
2.2
u/l
56.2
57.2
0.11
406
1426
(3023368) Bacteria identified in Blood by Culture
370
1416
4.54
84.35
8.7
3.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
250
735
4.80
80.00
4.9
2.6
mmol/l
0.8
0.8
6.70
241
667
(3024561) Albumin [Mass/volume] in Serum or Plasma
454
2184
4.26
71.67
14.5
3.5
g/l
30.4
35.2
44.85
439
1995
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
483
2438
4.40
70.88
30.8
3.6
umol/l
32.2
12.3
9.52
477
2270
(3021162) Amylase [Enzymatic activity/volume] in Specimen
64
0
+∞
67.86
3.5
0.0
u/l
322.7
—
—
56
0
(3032080) INR in Blood by Coagulation assay
445
2226
3.90
63.62
16.0
10.2
inr
1.3
1.4
1.41
128
620
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
160
403
4.89
60.54
9.6
2.1
u/l
48.0
36.2
0.62
155
324
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
333
1416
3.65
60.37
10.1
2.6
u/l
65.4
34.3
11.60
321
1339
(3042936) Bacteria identified in Isolate by Culture
216
710
4.00
57.16
2.6
2.0
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
159
438
4.43
53.25
6.7
5.9
mmol/l
7.7
10.9
5.38
151
410
(3044640) Blood type and Crossmatch panel - Blood
314
1401
3.31
50.67
4.2
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
132
334
4.66
49.05
1.5
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
52
64
8.72
39.82
2.3
1.3
g/l
1.0
0.7
0.50
38
50
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
385
2124
2.88
39.80
7.1
3.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
70
123
6.23
38.94
3.0
2.3
umol/l
34.3
35.8
0.18
58
105
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
28
13
22.42
37.63
2.0
1.1
umol/l
27.3
28.9
0.23
28
13
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
246
1097
2.95
37.54
4.0
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
115
321
4.11
37.08
1.6
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
65
117
6.04
35.23
1.5
1.1
titre
115.0
87.5
—
6
8
(3013650) Neutrophils [#/volume] in Blood by Automated count
431
2623
2.76
35.21
24.5
6.0
e9/l
4.4
4.3
0.22
400
2273
(40768804) Tissue Pathology biopsy report
284
1434
2.69
33.38
2.9
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
199
860
2.86
31.38
2.1
1.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
85
220
4.27
30.11
2.2
1.7
ug/l
4.0
1.6
0.60
80
187
(3015377) Calcium [Moles/volume] in Serum or Plasma
303
1670
2.47
28.59
8.0
2.1
mmol/l
2.3
2.4
3.15
286
1362
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
91
258
3.92
28.43
11.5
9.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
406
2578
2.43
27.56
9.2
5.4
mmol/l
1.2
1.2
6.13
335
2175
(3003694) ABO and Rh group [Type] in Blood
228
1130
2.53
26.74
1.4
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
377
2352
2.36
26.15
8.0
5.1
mmol/l
1.2
1.2
6.73
360
2075
(3003458) Phosphate [Moles/volume] in Serum or Plasma
159
668
2.80
25.93
4.3
4.5
mmol/l
1.0
1.0
0.02
152
597
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
63
156
4.35
23.53
3.0
2.7
u/ml
0.3
0.4
2.03
34
88
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
96
324
3.29
22.88
1.7
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
55
125
4.70
22.86
1.8
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
444
3078
2.28
22.57
9.9
4.2
mmol/l
7.4
6.9
4.84
432
2878
(42870588) Differential panel, method unspecified - Blood
267
1535
2.22
21.35
5.0
5.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
200
1028
2.34
20.85
9.8
2.3
mmol/l
2.5
2.4
6.59
190
872
(3022948) Iron [Moles/volume] in Serum or Plasma
168
802
2.45
20.67
2.5
2.3
umol/l
10.5
13.1
4.85
163
724
(3002173) Hemoglobin [Mass/volume] in Arterial blood
123
516
2.69
19.72
10.1
7.0
g/l
117.3
121.4
1.31
117
502
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
146
668
2.51
19.59
2.4
2.4
%
19.9
23.7
2.41
137
559
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
422
2961
2.12
19.50
9.5
2.9
u/l
272.4
49.5
27.07
398
2688
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
12
14.50
18.54
1.8
2.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
24
8
31.03
18.44
1.4
3.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
135
616
2.49
18.11
2.0
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
94
358
2.89
18.05
1.4
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
95
367
2.85
17.76
1.4
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
134
617
2.46
17.59
1.9
1.8
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
128
577
2.50
17.59
9.7
6.5
%
97.5
95.1
10.29
123
558
(3004789) Transferrin [Mass/volume] in Serum or Plasma
148
714
2.37
17.51
2.4
2.3
g/l
2.2
2.3
0.40
140
651
(3028026) IgM [Mass/volume] in Serum or Plasma
71
235
3.26
17.35
1.6
1.3
g/l
1.3
1.1
0.27
63
216
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
496
3807
2.12
16.71
32.7
5.1
u/l
201.6
76.6
33.90
489
3480
(3003396) Base excess in Arterial blood by calculation
134
638
2.37
16.24
9.7
6.3
mmol/l
0.3
1.5
3.44
112
485
(3005719) IgG [Mass/volume] in Serum or Plasma
79
291
2.94
16.06
2.4
2.2
g/l
11.5
10.9
0.63
69
267
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
134
643
2.35
15.94
9.7
6.3
kpa
5.0
5.1
0.80
127
614
(3027801) Oxygen [Partial pressure] in Arterial blood
134
643
2.35
15.94
9.7
6.3
kpa
14.2
11.4
7.09
125
613
(3018418) pH of Serum or Plasma
246
1499
2.01
15.85
4.8
3.2
ph
7.4
7.4
1.93
70
263
(3016650) Hepatitis A virus Ab [Presence] in Serum
35
74
4.93
15.81
1.1
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
329
2217
1.94
15.77
5.4
5.5
%
20.9
26.7
15.11
312
2035
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
24
36
6.87
15.39
1.9
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
43
110
4.11
15.35
4.6
3.6
mmol/l
2.7
3.0
0.26
34
71
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
33
69
4.98
15.10
1.1
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
248
1544
1.96
14.81
3.5
3.1
e6/l
63.3
109.5
0.46
205
1196
(3019069) Monocytes/100 leukocytes in Blood
321
2180
1.90
14.71
5.6
5.5
%
8.8
8.9
0.04
303
2014
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
94
404
2.54
14.14
4.9
2.7
mmol/l
1.2
1.2
2.70
88
346
(40768797) Stomach Pathology biopsy report
134
674
2.23
14.14
1.5
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
310
2108
1.87
13.92
5.4
5.3
%
0.5
0.7
8.81
290
1941
(3006504) Eosinophils/100 leukocytes in Blood
315
2173
1.84
13.33
5.5
5.3
%
2.2
2.9
7.91
297
2001
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
278
1852
1.85
13.12
3.7
3.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
317
2199
1.83
13.11
5.3
5.2
%
62.9
58.0
8.47
301
2034
(4281824)
17
21
8.28
12.80
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
37
98
3.94
12.60
2.3
3.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
84
363
2.50
12.45
3.6
3.9
%
1.4
0.7
0.99
46
82
(3006922) Hepatitis E virus Ab [Presence] in Serum
17
22
7.90
12.33
1.1
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
93
425
2.38
12.20
10.0
6.7
—
—
—
0
0
(3039000) Anion gap in Blood
40
117
3.57
11.84
9.2
6.7
mmol/l
11.0
11.2
0.13
35
110
(3018572) Chloride [Moles/volume] in Blood
40
117
3.57
11.84
9.2
6.7
mmol/l
106.0
105.6
0.22
35
110
(3018095) Leukocytes [#/volume] in Urine
264
1780
1.79
11.63
4.1
3.6
e6/l
54.8
128.5
2.13
218
1281
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
17
9
19.33
11.63
3.9
1.0
%
94.6
90.2
—
17
9
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
29
68
4.41
11.58
4.2
6.3
iu/ml
589.4
110.9
—
7
7
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
21
7.78
11.46
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
21
7.78
11.46
1.1
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
109
547
2.18
11.43
4.7
3.0
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
22
41
5.51
11.41
1.5
1.2
g/l
8.2
7.4
0.22
15
30
(4062490)
22
41
5.51
11.41
1.5
1.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
22
41
5.51
11.41
1.5
1.2
g/l
0.5
0.4
0.29
15
30
(3028192) IgG subclass 2 [Mass/volume] in Serum
22
41
5.51
11.41
1.5
1.2
g/l
3.4
2.7
0.66
15
30
(3019198) Lymphocytes [#/volume] in Blood
331
2393
1.75
11.37
5.3
5.2
e9/l
1.4
1.8
14.12
295
2093
(3026782) Osmolality of Urine
171
1013
1.92
11.37
3.1
2.5
mosm/kgh2o
554.4
548.5
0.12
153
844
(3006315) Basophils [#/volume] in Blood
325
2353
1.73
10.99
5.3
5.2
e9/l
0.0
0.0
5.01
282
2027
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
431
5123
0.57
10.88
4.3
5.5
mmol/l
2.6
2.6
0.65
363
4629
(3000850) Epithelial cells [#/volume] in Urine
179
1092
1.87
10.81
2.9
2.3
e6/l
7.0
5.0
1.21
161
946
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
60
236
2.69
10.75
7.2
4.4
%
1.7
1.6
0.62
55
228
(36304419) Bacteria [Presence] in Urine
209
1342
1.81
10.67
3.6
3.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
322
2340
1.72
10.63
5.3
5.2
e9/l
0.6
0.6
0.33
283
2006
(3030467) Casts [#/volume] in Urine by Automated count
217
1411
1.79
10.62
3.6
3.0
e6/l
0.7
0.4
0.75
175
1071
(3019060) Gas panel - Arterial blood
84
390
2.32
10.60
6.1
4.8
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
59
232
2.69
10.58
7.2
4.5
%
0.9
0.9
0.21
53
224
(3031040) Bacteria [#/volume] in Urine by Automated count
423
3314
1.73
10.57
5.4
4.5
e6/l
2.9
3230.5
—
7
57
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
68
1411
0.42
10.57
1.9
1.6
mmol/l
1.4
1.3
0.07
58
1162
(3013115) Eosinophils [#/volume] in Blood
330
2432
1.69
10.20
5.5
5.3
e9/l
0.2
0.2
6.66
289
2130
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
37
117
3.29
9.73
2.1
2.1
%
81.0
88.8
0.86
37
111
(3047181) Lactate [Moles/volume] in Blood
47
172
2.86
9.65
8.6
6.0
mmol/l
1.4
1.3
0.53
41
155
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
44
4.89
9.59
1.3
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
72
327
2.34
9.54
3.5
4.0
%
0.8
0.3
1.82
33
61
(40758558) Short blood count panel - Blood
177
1117
1.79
9.42
17.6
4.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
53
210
2.65
9.37
2.2
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
423
4996
0.59
9.35
4.1
4.9
mmol/l
4.4
4.5
1.32
360
4533
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
417
4942
0.60
9.33
4.1
4.8
mmol/l
1.3
1.4
4.73
347
4452
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
71
3.92
9.31
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
74
347
2.27
9.11
3.8
4.0
%
0.2
0.1
0.85
40
72
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
428
5029
0.60
9.06
4.6
5.0
mmol/l
6.3
6.1
1.37
370
4498
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
381
4598
0.61
8.90
4.4
4.6
mu/l
2.3
2.3
0.01
325
4103
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
43
4.76
8.87
1.4
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
20
43
4.76
8.87
1.4
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
93
3.44
8.86
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
26
70
3.82
8.69
1.2
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
36
5.11
8.66
2.3
3.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
20
44
4.65
8.64
1.4
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
20
44
4.65
8.64
1.4
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
70
333
2.23
8.32
3.7
4.1
%
0.1
1.4
0.47
37
64
(3042733) HLA Ab [Presence] in Serum
13
9
14.69
8.22
1.5
6.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
42
4.63
8.16
1.4
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
48
196
2.56
8.00
2.1
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
31
100
3.20
7.92
2.1
2.6
%
15.1
16.6
—
10
47
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
29
90
3.32
7.88
1.7
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
12
8
15.24
7.73
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
12
8
15.24
7.73
1.1
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
30
97
3.19
7.64
1.6
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
75
380
2.09
7.61
8.0
7.3
mmol/l
23.9
24.6
0.81
69
358
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
68
3.62
7.48
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
29
5.27
7.48
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
29
5.27
7.48
2.1
2.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
12
9
13.54
7.40
1.5
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
93
515
1.93
7.37
3.1
3.2
mmol/l
1.4
2.1
0.82
75
414
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
417
4851
0.64
7.23
7.5
6.6
mmol/mol
41.9
40.9
1.25
375
4435
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
20
52
3.93
7.02
1.2
2.3
—
281.2
—
0
6
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
23
67
3.52
6.89
1.3
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
223
1608
1.58
6.80
2.6
3.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
22
63
3.58
6.76
2.0
2.0
%
92.1
89.9
1.77
22
63
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
69
3.42
6.60
1.1
1.1
u/ml
343.1
269.7
0.31
17
36
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
412
4771
0.65
6.53
3.9
4.3
mmol/l
1.3
1.3
0.04
349
4255
(40760892) CBC W Ordered Manual Differential panel - Blood
147
967
1.66
6.49
4.0
4.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
22
66
3.41
6.32
1.5
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
26
87
3.07
6.29
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
125
800
1.69
6.10
3.2
2.9
e6/l
3.3
2.5
0.25
72
436
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
19
53
3.66
6.07
2.8
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
98
587
1.78
6.05
1.8
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
64
335
2.01
5.96
1.8
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
36
4.24
5.85
1.3
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
24
5.07
5.76
3.5
2.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
79
450
1.86
5.74
1.6
1.7
%
1.6
1.6
0.02
64
374
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
27
99
2.80
5.59
1.1
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
20
62
3.29
5.48
1.6
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
310
3731
0.69
5.36
3.9
3.7
pmol/l
15.2
15.0
0.49
258
3320
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
58
3.34
5.34
1.6
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
125
834
1.61
5.15
16.9
27.2
inr
1.4
1.4
0.18
21
109
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
23
82
2.87
5.02
3.6
2.9
%
62.5
60.5
0.22
23
82
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
182
1335
1.50
4.89
2.5
2.2
mg/l
3.4
3.0
0.61
161
1109
(3030981) Hyaline casts [#/volume] in Urine by Automated count
54
288
1.95
4.80
2.3
2.5
e6/l
1.6
0.2
1.34
54
278
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
26
102
2.61
4.77
1.7
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
33
4.00
4.73
1.5
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
68
395
1.80
4.65
4.4
3.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
108
1569
0.63
4.65
3.0
3.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
43
3.54
4.63
1.5
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
5
14.12
4.58
10.7
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
18
59
3.11
4.54
1.6
1.4
—
—
—
0
0
(3020891) Body temperature
48
251
1.98
4.52
4.4
4.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
71
2.87
4.42
1.6
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
43
218
2.04
4.41
1.3
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
44
228
1.99
4.26
1.1
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
132
1795
0.67
4.06
3.9
3.8
%
20.5
24.4
3.00
64
878
(3000963) Hemoglobin [Mass/volume] in Blood
508
5510
0.69
4.06
63.1
20.2
g/l
119.0
135.6
87.07
500
5385
(3010813) Leukocytes [#/volume] in Blood
508
5510
0.69
4.06
62.7
20.1
e9/l
7.7
6.8
12.44
497
5307
(3026361) Erythrocytes [#/volume] in Blood
508
5510
0.69
4.06
62.7
20.1
e12/l
4.0
4.5
60.00
495
5301
(3024731) MCV [Entitic volume]
508
5509
0.69
4.05
62.5
20.0
fl
90.9
91.6
2.59
500
5386
(3035941) MCH [Entitic mass]
508
5509
0.69
4.05
62.5
20.0
pg
30.1
30.5
5.74
500
5386
(3007461) Platelets [#/volume] in Blood
508
5508
0.69
4.03
62.7
20.1
e9/l
254.5
240.5
3.83
497
5320
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
7
10.09
4.01
1.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
151
1112
1.46
3.89
3.9
4.1
ng/l
580.3
369.9
0.18
124
944
(3017732) Neutrophils [#/volume] in Blood
52
296
1.82
3.83
5.1
3.0
e9/l
5.2
4.0
0.93
42
211
(3018405) Lactate [Moles/volume] in Arterial blood
43
230
1.93
3.83
4.0
4.1
mmol/l
1.6
1.5
0.21
43
225
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
55
2.96
3.76
1.3
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
174
2224
0.71
3.75
4.1
4.0
ug/l
1.9
2.1
0.70
143
1971
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
80
2.55
3.57
2.8
2.6
e9/l
5.3
4.8
0.16
20
80
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
9
7.84
3.56
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
86
1243
0.65
3.52
2.7
2.7
ug/l
0.6
0.8
2.76
57
861
(40768795) Lymph node Pathology biopsy report
8
13
6.21
3.51
1.3
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
272
2249
1.35
3.50
4.2
4.0
ng/l
24.0
79.5
1.87
227
1692
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
48
794
0.57
3.45
1.3
1.3
iu/ml
55.7
40.8
0.22
15
243
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
29
140
2.12
3.42
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
120
866
1.47
3.42
3.0
2.7
e6/l
1.7
1.3
0.38
66
502
(3051611) Lipemic interference index of Serum or Plasma
13
42
3.14
3.38
3.9
2.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
14
5.77
3.35
1.9
1.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
132
1736
0.70
3.28
1.9
2.2
u/l
152.2
271.5
1.58
120
1613
(3037467) Urinalysis macro (dipstick) panel - Urine
396
3484
1.33
3.24
4.9
4.2
—
—
—
0
0
(3019225) pH of Specimen
77
515
1.56
3.14
5.1
3.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
20
4.55
3.12
1.3
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
20
4.55
3.12
1.3
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
109
786
1.46
3.11
1.5
1.3
g/l
2.6
2.8
0.69
72
453
(3044007) Cell count panel - Peritoneal fluid
6
9
6.71
2.87
2.0
3.3
—
—
—
0
0
(44806118)
13
47
2.80
2.83
1.8
1.4
—
—
—
0
0
(44790049)
13
47
2.80
2.83
1.8
1.4
—
—
—
0
0
(44790048)
13
47
2.80
2.83
1.8
1.4
—
—
—
0
0
(44790047)
13
47
2.80
2.83
1.8
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
66
437
1.57
2.83
1.3
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
36
3.09
2.82
2.0
2.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
23
3.95
2.78
1.3
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
52
327
1.64
2.75
3.1
3.8
ph
7.5
7.4
—
5
39
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
46
284
1.66
2.62
1.8
2.4
%
1.1
1.1
0.25
46
284
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
74
2.33
2.60
1.2
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
38
2.93
2.59
1.1
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
159
1263
1.34
2.56
4.0
3.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
44
2.76
2.56
1.6
1.8
%
13.6
10.6
2.10
12
44
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
49
312
1.61
2.49
3.2
3.8
mmol/l
2.0
2.0
0.02
33
231
(3042631) Mycobacterium sp identified in Specimen
14
57
2.49
2.46
1.9
2.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
34
2.97
2.42
1.2
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
27
3.36
2.40
1.0
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
277
0.42
2.39
1.4
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
52
769
0.65
2.36
1.3
1.3
u/ml
1.4
13.4
5.18
18
295
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
44
278
1.62
2.32
1.9
2.4
%
0.7
0.7
0.38
44
267
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
41
2.71
2.28
1.4
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
13
4.65
2.27
1.0
2.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
11
42
2.65
2.19
1.2
1.2
e6/l
28098.3
182303.9
—
6
27
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
29
166
1.78
2.18
2.2
3.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
14
4.31
2.15
3.0
2.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
224
1904
1.26
2.13
4.2
3.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
435
4694
0.80
2.12
43.1
12.7
ml/min/173m2
79.9
74.1
7.64
387
3790
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
33
199
1.69
2.09
3.7
2.9
pmol/l
4.2
4.5
0.75
28
169
(3006184) Hemoglobin [Mass/volume] in Capillary blood
22
117
1.91
2.08
1.6
2.3
g/l
117.1
133.7
1.95
16
84
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
20
3.53
2.06
1.9
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
13
56
2.35
2.06
1.1
1.2
g/l
36.4
25.8
1.89
13
49
(3022145) Colonoscopy Study observation
66
470
1.45
2.05
1.7
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
44
2.52
2.02
1.4
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
26
3.10
2.02
1.3
1.2
—
—
—
0
0
(3013512) EKG study
196
1652
1.26
1.99
3.9
4.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
80
594
1.39
1.98
1.5
1.3
titre
362.7
499.5
0.56
15
148
(3029937) Albumin [Presence] in Urine by Test strip
166
1372
1.28
1.98
4.7
3.9
estimate
0.0
0.0
0.00
62
409
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
503
5324
0.79
1.97
35.6
9.1
u/l
43.1
25.3
25.01
495
5066
(3024928) Oxygen saturation in Venous blood
23
127
1.84
1.96
2.2
2.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
120
1.86
1.95
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
120
1.86
1.95
1.6
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
11
4.57
1.94
2.2
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
228
1960
1.25
1.94
2.8
2.7
ug/l
209.4
139.2
2.89
215
1757
(3012516) Albumin [Mass/volume] in Urine
149
1796
0.78
1.91
3.0
3.2
mg/l
47.7
217.9
1.56
91
1128
(3022313) Gas panel - Capillary blood
38
245
1.58
1.88
3.4
3.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
506
5342
0.79
1.85
49.3
17.0
mmol/l
3.9
4.0
6.21
498
5173
(3009508) Creatinine [Moles/volume] in Urine
154
1836
0.79
1.79
2.9
3.1
mmol/l
7.5
7.4
0.05
113
1525
(3007853) Bacteria identified in Skin by Aerobe culture
77
582
1.36
1.73
1.8
1.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
234
2039
1.23
1.73
2.6
2.2
nmol/l
69.7
78.7
5.06
218
1750
(3019550) Sodium [Moles/volume] in Serum or Plasma
506
5330
0.80
1.72
49.3
16.9
mmol/l
137.7
139.7
37.43
498
5166
(21494815) CD4 cells/100 lymphocytes in Specimen
6
19
3.18
1.66
1.0
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
162
1903
0.80
1.63
3.9
3.9
mg/mmol
8.0
7.9
0.02
94
1197
(3049717) Cytology report of Urine Cyto stain
28
174
1.64
1.63
3.0
1.8
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
12
56
2.16
1.62
3.3
2.5
ml
622.9
634.3
—
7
41
(3010503) CD19 cells [#/volume] in Blood
5
14
3.59
1.62
1.8
1.2
e9/l
0.8
0.2
—
5
14
(3052851) Hemolysis interference index of Serum or Plasma
24
144
1.69
1.59
3.6
3.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
36
240
1.53
1.58
1.6
1.5
g/l
1.5
1.6
0.22
30
201
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
72
1.96
1.49
2.1
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
87
1.86
1.47
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
154
0.45
1.44
1.1
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
277
2490
1.19
1.43
4.1
3.8
estimate
0.0
0.0
0.00
69
418
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
20
324
0.61
1.41
2.2
2.6
—
14.7
—
0
6
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
35
500
0.68
1.39
1.8
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
42
2.16
1.34
1.1
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
18
2.79
1.28
4.6
6.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
18
2.79
1.28
2.0
2.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
272
2459
1.18
1.28
4.1
3.7
estimate
0.0
0.0
0.00
70
423
(3037756) Immunofixation for Serum or Plasma
15
84
1.80
1.28
1.4
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
238
2134
1.18
1.23
26.5
8.6
e9/l
0.0
0.0
0.45
194
1743
(4094501)
7
144
0.48
1.21
1.4
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
19
298
0.63
1.20
1.1
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
14
237
0.58
1.20
1.4
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
6
26
2.32
1.19
1.2
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
55
422
1.33
1.18
2.2
1.8
nmol/l
412.5
359.3
0.97
50
384
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
72
574
1.28
1.17
2.0
2.5
ug/l
3.9
6.9
1.94
66
498
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.4
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.4
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.4
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
270
2457
1.16
1.15
5.1
5.1
estimate
0.0
0.0
0.00
70
418
(40761511) CBC panel - Blood by Automated count
493
5146
0.85
1.13
43.0
13.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
30
2.35
1.12
2.9
2.5
—
—
—
0
0
(3000492) Spirometry study
27
385
0.69
1.10
1.2
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
122
0.49
1.06
1.0
1.2
—
2.2
—
0
14
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
19
288
0.65
1.05
1.1
1.4
—
45.7
—
0
12
(3006462) Nitrate [Presence] in Urine
5
22
2.28
1.03
1.6
3.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
58
458
1.29
1.03
2.4
2.1
ug/g
205.9
170.7
0.26
48
364
(3001019) Free T4 and TSH panel - Serum or Plasma
5
110
0.45
1.00
1.0
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
11
61
1.82
0.99
1.0
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
187
0.58
0.99
1.6
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
27
2.23
0.93
1.0
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
52
1.74
0.92
1.2
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
28
2.15
0.91
2.2
1.3
g/l
0.9
1.0
—
6
28
(40768793) Breast Pathology biopsy report
6
28
2.15
0.91
1.2
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
205
1858
1.15
0.90
3.5
3.0
ng/l
1569.2
1766.7
0.20
178
1578
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
116
1006
1.18
0.89
2.8
1.7
mg/l
3.2
1.3
2.04
102
784
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
7
129
0.54
0.88
1.0
1.2
—
21.9
—
0
7
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
61
742
0.80
0.87
16.0
7.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
30
2.01
0.87
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
13
80
1.64
0.85
1.5
2.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
78
657
1.21
0.83
1.9
1.9
%
1.7
1.7
0.09
70
579
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
46
1.75
0.82
1.0
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
47
1.71
0.81
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
25
0.00
0.79
0.0
1.1
—
37.1
—
0
13
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
2.2
—
1370.3
—
0
25
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
5
97
0.51
0.78
1.0
1.2
—
37.0
—
0
9
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
124
0.56
0.78
1.0
1.2
—
4.6
—
0
19
(3023520) Reticulocytes [#/volume] in Blood
59
486
1.23
0.78
1.8
2.0
e9/l
62.7
67.7
0.50
46
389
(4027681)
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
83
1.58
0.75
1.0
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
10
159
0.62
0.73
1.3
1.2
—
0.2
—
0
13
(3026493) Urate [Moles/volume] in Serum or Plasma
124
1390
0.87
0.72
2.5
2.5
umol/l
358.2
9258.9
6.66
104
1163
(3045788) Cell count panel - Pleural fluid
7
40
1.76
0.71
1.1
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
58
688
0.83
0.68
4.0
5.1
%
33.0
32.3
0.16
34
428
(3044290) Cell count panel - Cerebral spinal fluid
5
94
0.53
0.67
1.2
1.1
—
—
—
0
0
(4211845)
5
28
1.79
0.66
1.6
3.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
8
131
0.61
0.64
1.1
1.3
mg/l
414.6
525.6
—
8
121
(4010399)
31
390
0.79
0.62
1.2
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
103
0.58
0.62
1.0
1.2
—
2.7
—
0
7
(3021960) Folate [Moles/volume] in Serum or Plasma
129
1426
0.88
0.62
1.8
1.6
nmol/l
20.6
20.7
0.05
123
1194
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
88
1.49
0.61
1.0
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
88
1.49
0.61
1.8
2.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(44813793)
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
112
0.62
0.58
1.6
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
112
0.62
0.58
1.1
1.2
mmol/l
4.6
3.9
—
7
103
(4034850)
14
196
0.71
0.58
25.1
11.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
21
159
1.33
0.56
3.8
4.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
146
0.68
0.52
1.1
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
107
0.65
0.49
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
108
0.64
0.49
1.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
128
1.34
0.48
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
120
1.34
0.46
1.9
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
118
0.67
0.46
1.5
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
164
0.73
0.45
1.5
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
78
1.42
0.43
3.0
2.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
31
1.62
0.43
3.4
2.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
92
0.65
0.42
1.0
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
229
2410
0.92
0.42
2.8
2.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
21
167
1.27
0.42
3.5
2.4
ug/min
85.0
90.2
0.05
11
105
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
18
228
0.78
0.42
1.1
1.2
iu/ml
467.3
111.3
—
6
87
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
70
1.43
0.42
1.1
1.7
pg
35.8
33.2
—
10
70
(3000285) Sodium [Moles/volume] in Blood
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
17
0.00
0.40
0.0
1.2
—
1.2
—
0
17
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
13
97
1.35
0.39
1.2
1.4
mmol/l
58.9
63.7
—
7
80
(3051593) INR in Capillary blood by Coagulation assay
5
35
1.43
0.39
25.2
13.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
48
420
1.15
0.39
4.2
2.4
ml/min/173m2
69.1
60.5
0.95
24
170
(3000475) Leukocytes [#/volume] in Synovial fluid
17
133
1.29
0.39
1.8
1.6
e6/l
16058.4
15488.9
0.02
11
92
(3041354) Potassium [Moles/volume] in Venous blood
11
80
1.38
0.38
3.0
2.2
mmol/l
4.0
4.1
0.55
11
80
(3035285) Chloride [Moles/volume] in Venous blood
11
80
1.38
0.38
3.0
2.2
mmol/l
106.1
105.2
0.27
11
80
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
38
439
0.86
0.37
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
180
0.77
0.37
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
44
1.37
0.34
1.3
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
86
0.70
0.33
2.0
2.2
—
—
—
0
0
(3044889) 12 lead EKG panel
360
3702
0.94
0.32
4.9
4.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
143
0.77
0.32
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
141
0.78
0.29
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
141
0.78
0.29
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
16
194
0.82
0.28
1.1
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
231
2394
0.95
0.26
2.2
2.1
pmol/l
92.4
93.2
0.09
136
1214
(3045424) Erythrocytes [Presence] in Urine
8
67
1.20
0.26
2.0
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
72
0.69
0.26
1.2
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
5
74
0.67
0.26
1.0
1.5
%
42.6
68.0
—
5
45
(3037121) Protein [Mass/volume] in Urine
15
181
0.82
0.25
4.7
2.1
g/l
0.3
0.3
—
8
55
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
87
1.27
0.24
1.1
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
19
161
1.19
0.24
1.2
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
87
926
0.93
0.23
1.2
1.2
u/ml
5.0
1.7
0.55
21
261
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
21
182
1.16
0.21
1.5
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
42
1.19
0.21
1.4
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
18
208
0.86
0.20
1.8
2.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
14
0.00
0.20
0.0
1.1
—
14.4
—
0
9
(40760888) Immunoglobulin light chains.free panel - Serum
9
113
0.79
0.20
7.0
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
501
4947
1.05
0.20
47.4
13.7
mg/l
42.0
24.6
20.72
492
3889
(3022621) pH of Urine by Test strip
39
356
1.10
0.19
3.4
3.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
52
1.16
0.19
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
48
518
0.92
0.18
1.3
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
371
3776
0.96
0.18
4.6
4.1
mm/h
22.0
12.9
12.10
334
3417
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
59
1.19
0.18
4.3
3.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
120
1.17
0.16
1.4
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
70
1.14
0.16
1.3
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
122
1174
1.05
0.16
4.6
4.1
kg/l
1.0
1.0
0.07
24
181
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
76
0.79
0.15
1.2
1.2
nmol/l
0.5
0.6
—
6
68
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
78
1.16
0.15
1.2
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
40
372
1.08
0.14
1.5
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
118
1215
0.97
0.11
2.0
1.8
nmol/l
1275.6
1190.1
0.43
99
904
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
41
433
0.94
0.10
2.4
3.6
ng/l
58.8
89.3
4.65
41
373
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(4268621)
5
46
1.09
0.09
2.0
2.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
13
145
0.89
0.09
3.6
3.2
nmol/l
0.6
0.9
—
8
114
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
155
0.90
0.09
1.7
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
62
0.81
0.08
1.8
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
63
0.79
0.08
1.4
1.1
—
—
—
0
0
(4306422)
5
64
0.78
0.08
1.4
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
65
0.77
0.08
1.8
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
430
4333
0.98
0.08
39.3
15.1
%
34.3
39.5
13.52
257
2712
(4146454)
6
72
0.83
0.07
3.0
2.8
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
6
75
0.80
0.07
1.2
1.2
nmol/l
—
0.7
—
0
6
(3011397) Hemoglobin [Presence] in Urine by Test strip
124
1216
1.02
0.07
3.6
3.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
93
0.86
0.06
1.5
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
193
0.93
0.06
1.3
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
49
480
1.02
0.02
4.0
3.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
30
291
1.03
0.02
3.2
3.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
93
1.08
0.02
1.5
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
157
0.95
0.01
1.3
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
217
0.97
0.01
1.2
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
97
1.03
0.00
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
32
324
0.99
0.00
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
288
1.01
0.00
2.3
2.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
121
0.99
0.00
1.9
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
128
1278
1.00
0.00
1.7
1.7
pmol/l
151402366.2
18324020.4
0.42
107
1026
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
2.4
—
0.6
—
0
5
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
66
0.91
0.00
1.2
1.3
nmol/l
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
16.9
—
0
5
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
8
0.00
0.00
0.0
5.6
—
6.3
—
0
8
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
102.6
—
0
5
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
5
51
0.98
0.00
1.6
2.5
—
1.6
—
0
17
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
76.0
—
0
8
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
1.9
—
0
7
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
-0.00
0.0
5.7
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
-0.00
0.0
1.0
—
24.4
—
0
6
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BILIARY_TRACT_EXALLC – Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).